Mucosal Vaccination for Influenza Protection Enhanced by Catalytic Immune‐Adjuvant

Influenza poses a severe threat to global health. Despite the whole inactivated virus (WIV)‐based nasal vaccine being a promising strategy for influenza protection, the mucosal barrier is still a bottleneck of the nasal vaccine. Here, a catalytic mucosal adjuvant strategy for an influenza WIV nasal...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Adv Sci (Weinh)
Prif Awduron: Qin, Tao, Ma, Shang, Miao, Xinyu, Tang, Yan, Huangfu, Dandan, Wang, Jinyuan, Jiang, Jing, Xu, Nuo, Yin, Yuncong, Chen, Sujuan, Liu, Xiufan, Yin, Yinyan, Peng, Daxin, Gao, Lizeng
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2020
Pynciau:
Full Papers
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7509716/
https://ncbi.nlm.nih.gov/pubmed/32999833
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/advs.202000771
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg